What Is a Clinical Trial — and Should You Join One?
The two things that stop most families from considering a trial are the fear of getting a placebo and the fear of extra costs. Both are worth addressing directly before you decide.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Not placebo vs. nothing — Most cancer trials compare a new treatment against the current standard of care — not against an empty injection.
- Voluntary and reversible — You sign consent before anything begins and can withdraw at any time without it affecting your access to treatment.
- The drug is usually free — The trial sponsor typically provides the experimental treatment at no cost. Ask specifically about all other expenses.
- More monitoring, not less — Trial participants are usually seen more often than patients on standard care — not less closely.
on Panel
Survival Rate*
Treated
(800+ reviews)
Most cancer trials in India do not give a placebo alone — you receive either the new treatment or the current best standard of care. Participating is voluntary, you can withdraw at any time, and the experimental drug is usually provided free. Whether a trial is right for you depends on your cancer type, stage, and which trials are currently open.
How does joining a clinical trial actually work?
Your oncologist checks whether a trial matches your situation
Trials have strict inclusion criteria — cancer type, stage, prior treatments, and general fitness. Your oncologist checks these against open trials registered with the Clinical Trials Registry India (CTRI). Not every patient will have a matching trial available.
You receive a full information sheet and time to read it
Before you are asked to decide anything, you are given a patient information sheet in a language you understand. You are entitled to ask questions and to take time — days if you need them — before deciding.
You sign an Informed Consent Document
CDSCO requires written informed consent before any trial procedure begins. Signing means you understand what you are agreeing to — not that you are locked in. You can withdraw at any point after this.
You are assigned to a treatment group
In randomised trials, assignment is done by chance, not by choice. In most cancer trials the control group receives the current standard treatment, not a placebo. The information sheet will state exactly what each group receives before you sign.
You attend scheduled visits and are monitored closely
Trial participants are usually seen more frequently than patients on standard care. Blood tests, scans, and questionnaires track how you are responding and watch for any early signs of problems.
You can withdraw at any point
Leaving a trial does not affect your right to treatment. Your oncologist will discuss what comes next and move you to the best available standard care.
Will you get a placebo and miss your real treatment?
In cancer trials, a placebo alone is almost never used as the control. ASCO and ICMR ethics guidance does not permit withholding effective treatment from participants when one already exists.
If a trial has two groups, the control group receives the current best available treatment. The new treatment is being tested against that standard — not against nothing.
Before you sign consent, the information sheet must state exactly what each group receives. If anything is unclear, ask your team to explain it in plain language before you decide.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
What questions should you ask before joining a trial?
- What does the control group receive — the current standard treatment or a placebo?
- What are the chances of being assigned to each group?
- Is the experimental drug provided free? What other costs will I have?
- How many extra visits will I need, and will travel costs be covered?
- Can I leave the trial if my cancer is not responding?
- Who do I contact if I have a side effect between visits?
- Will I be told which group I was in once the trial ends?
- Will the overall results be shared with me when they are published?
Will joining a trial cost you more money?
The experimental treatment itself is almost always provided free by the trial sponsor. For newer treatments not yet approved in India, trial participation may be the only way to access them at all.
What may not be covered varies by trial — additional monitoring tests, travel to the trial centre, and hospital costs outside the protocol. Ask your trial coordinator to go through every potential expense before you sign.
If you are weighing costs, ask what the same treatment would cost outside a trial. That comparison is often the clearest way to see whether the trial is financially better, worse, or similar to your current path.
Did you know?
Every clinical trial in India must be registered with the Clinical Trials Registry India (CTRI) and approved by an accredited Independent Ethics Committee before it can enrol a single participant.
These are not internal checks run by the sponsor — they are regulatory requirements enforced by CDSCO. If a trial is not registered on CTRI, do not join it.
Source: CDSCO Schedule Y, Drugs and Cosmetics Act; ICMR National Ethical Guidelines for Biomedical and Health Research
Explore 52 more Cost, Access, Trials & Choosing a Hospital topics
Clinical Trials & Access Programs
- Basket and Umbrella Trials: The New Way Trials Are Designed
- Eligibility Criteria: Why Patients Get Rejected From Trials
- How to Find Cancer Clinical Trials in India
- Phase 1, 2 and 3 Trials: What the Numbers Mean for You
- Risks, Consent and Your Right to Withdraw
- What Happens After a Trial Ends?
- What Is a Clinical Trial and Should You Join One?
- Who Pays for Treatment in a Clinical Trial?
- Will I Get a Placebo Instead of Real Treatment?
Cost, Insurance & Access in India
- Are Generic Targeted Therapy Drugs Safe and Effective?
- Biosimilars for Trastuzumab, Bevacizumab and Rituximab in India
- CGHS, ECHS, ESI and State Schemes for Cancer Drugs
- Can You Get Targeted Therapy in a Government Hospital?
- Compassionate Access and Expanded Access Programs Explained
- Cost of NGS Testing vs the Cost of Treating Blindly
- Cost of Targeted Therapy in India: Monthly Price Guide by Drug Class
- Does Ayushman Bharat Cover Targeted Therapy?
- Hidden Costs Nobody Warns You About in Cancer Treatment
- How to File a Cancer Treatment Insurance Claim Without Rejection
- How to Talk to Your Doctor About Affording Treatment
- Importing a Cancer Drug Not Available in India
- NGOs and Crowdfunding for Cancer Treatment in India
- Patient Assistance Programs for Targeted Therapy Drugs in India
- Section 80DDB and Tax Deductions for Cancer Treatment
- Total Cost of Care: Targeted Therapy vs Chemotherapy Compared
- What Happens If You Have to Stop Treatment Because of Cost?
- Will Health Insurance Pay for Oral Cancer Tablets Taken at Home?
Hospital Choice, Second Opinion & Decision Pages
- A Guide for International and NRI Patients Seeking Cancer Care in India
- Day Care Infusion Centres: What to Expect on Infusion Day
- Documents to Bring to Your First Oncology Consultation
- Follow-Up on Oral Targeted Therapy: In Person or Teleconsult?
- Getting a Second Opinion on Your Targeted Therapy Plan
- How a Molecular Tumour Board Reviews Your Case
- How to Choose a Hospital for Targeted Therapy in India
- Medical Oncologist vs Precision Oncology Specialist: Who Do You Need?
- Online and Teleconsultation Second Opinions: How They Work
- Red Flags: Signs Your Cancer Care May Not Be Up to Standard
- Transferring Your Care to Another Hospital Mid-Treatment
- What a Good Second Opinion Actually Checks: A 10-Point Audit
- What a Precision Oncology Program Should Include: A Checklist
- What to Ask Before Committing to a Cancer Treatment Plan
Work, Travel, Legal & Insurance Rights
- Buying Life or Health Insurance After a Cancer Diagnosis
- Can You Keep Working Full Time on Targeted Therapy?
- Disability Certificate for Cancer Patients in India: How to Apply
- Flying With Cancer: Fitness to Fly and Airline Rules
- Making a Will and Organising Documents During Serious Illness
- Managing Fatigue and Meetings: Practical Workday Strategies
- Planning a Holiday Around Your Treatment Schedule
- Returning to Work After a Treatment Break
- Should You Tell Your Employer About Your Cancer Diagnosis?
- Sick Leave and Employment Rights for Cancer Patients in India
- Travel Insurance When You Have Cancer
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Frequently asked questions
Is a clinical trial just an experiment that uses patients as guinea pigs?
A clinical trial is not an experiment without oversight — every trial in India requires approval from an Independent Ethics Committee and registration with CTRI before it can begin. Informed consent is mandatory: you receive a plain-language explanation, have time to ask questions, and sign before anything starts. The ethics committee's role is to ensure that the risks to participants are proportionate to the potential benefit. These protections are legally required under CDSCO oversight, not left to the sponsor's discretion.
What if my cancer gets worse while I am on a trial?
Trials have predefined rules for when a participant should be taken off the trial treatment. If your cancer is not responding or your side effects are unacceptable, the protocol specifies that you come off — you are not kept on a failing treatment just to complete the study. Once you leave, your oncologist discusses what comes next from the standard options available to you. Joining a trial does not close off other treatments.
Can I join a trial and also continue my current treatment?
It depends on the trial protocol. Some trials allow or require that you continue certain treatments alongside the experimental one. Others require that you have stopped previous treatment before enrolling. The eligibility criteria — which you receive before you sign anything — will state this clearly. If you are not sure, ask the trial coordinator to explain which of your current treatments are compatible with the trial before you commit.
How do I find out if there is a trial for my cancer type?
Ask your oncologist first — they are best placed to match your diagnosis, stage, and prior treatment history against what is currently open. The Clinical Trials Registry India (CTRI) lists all registered trials in India and is publicly searchable online. CION's team can also check what is open across the network. Not every cancer type will have a relevant trial open at any given time, and being told there is no current match is not a sign that trials are unavailable in general.
Will I be told the results of the trial once it ends?
You can ask, and you should ask before you join. ICMR guidelines encourage that participants be informed of trial outcomes, and many sponsors provide a summary once the study closes. Some trials also notify participants of which group they were in once the blinding is lifted. This is not uniformly guaranteed, so ask specifically: whether you will be told your group assignment, and whether the overall results will be shared with you when they are published.